Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Impaired VEGF and nitric oxide signaling after nitrofen exposure in rat fetal lung explants.

Muehlethaler V, Kunig AM, Seedorf G, Balasubramaniam V, Abman SH.

Am J Physiol Lung Cell Mol Physiol. 2008 Jan;294(1):L110-20. Epub 2007 Nov 9.

2.

ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn.

Kunig AM, Parker TA, Nogee LM, Abman SH, Kinsella JP.

J Pediatr. 2007 Sep;151(3):322-4.

PMID:
17719949
3.

Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia.

Kunig AM, Balasubramaniam V, Markham NE, Seedorf G, Gien J, Abman SH.

Am J Physiol Lung Cell Mol Physiol. 2006 Nov;291(5):L1068-78. Epub 2006 Jul 7.

4.

BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.

Deruelle P, Balasubramaniam V, Kunig AM, Seedorf GJ, Markham NE, Abman SH.

Biol Neonate. 2006;90(2):135-44. Epub 2006 Mar 19.

PMID:
16582538
5.

Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats.

Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH.

Am J Physiol Lung Cell Mol Physiol. 2005 Oct;289(4):L529-35. Epub 2005 May 20.

6.

Cardiocirculatory performance at high altitude.

Kunig AM, Kunig HE.

Biomed Sci Instrum. 2004;40:309-10.

PMID:
15133976
7.

Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response?

Guida JD, Kunig AM, Leef KH, McKenzie SE, Paul DA.

Pediatrics. 2003 Jun;111(6 Pt 1):1411-5.

PMID:
12777561

Supplemental Content

Loading ...
Support Center